anmelden
Pfizer Aktie
23,06
EUR
-0,39
EUR
-1,64
%
26,60
USD
-0,01
USD
-0,02
%
nachbörslich
Pfizer jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Marktkap. 133,56 Mrd. EUR
KGV 18,36 Div. Rendite 6,91%WKN 852009
ISIN US7170811035
Symbol PFE
AI Analyse
Werbung
Pfizer Aktie Analyse
| 02.10.15 | Pfizer overweight | Morgan Stanley | |
| 02.10.15 | Pfizer overweight | Morgan Stanley | |
| 10.09.15 | Pfizer buy | Jefferies & Company Inc. | |
| 10.08.15 | Pfizer buy | Goldman Sachs Group Inc. | |
| 07.08.15 | Pfizer buy | Jefferies & Company Inc. | |
| 30.07.15 | Pfizer Outperform | Bernstein Research | |
| 29.07.15 | Pfizer Buy | Argus Research Company | |
| 30.04.15 | Pfizer Buy | Argus Research Company | |
|
Werbung
|
|||
| 13.02.15 | Pfizer Outperform | BMO Capital Markets | |
| 28.01.15 | Pfizer Buy | Argus Research Company | |
| 18.12.14 | Pfizer Buy | Deutsche Bank AG | |
| 02.05.14 | Pfizer kaufen | Norddeutsche Landesbank (Nord/LB) | |
| 07.04.14 | Pfizer buy | Jefferies & Company Inc. | |
| 04.02.14 | Pfizer kaufen | Jefferies & Company Inc. | |
| 30.10.13 | Pfizer kaufen | Independent Research GmbH | |
| 03.07.13 | Pfizer kaufen | Citigroup Corp. | |
| 14.12.12 | Pfizer overweight | JP Morgan Chase & Co. | |
| 03.12.12 | Pfizer buy | Citigroup Corp. | |
| 14.11.12 | Pfizer buy | Jefferies & Company Inc. | |
| 02.11.12 | Pfizer buy | UBS AG | |
| 16.10.12 | Pfizer buy | Jefferies & Company Inc. | |
| 10.10.12 | Pfizer buy | Goldman Sachs Group Inc. | |
| 13.08.12 | Pfizer buy | Jefferies & Company Inc. | |
| 07.08.12 | Pfizer buy | UBS AG | |
| 02.08.12 | Pfizer buy | Banc of America Securities-Merrill Lynch | |
| 02.08.12 | Pfizer outperform | Sanford C. Bernstein and Co., Inc. | |
| 02.08.12 | Pfizer buy | Goldman Sachs Group Inc. | |
| 01.08.12 | Pfizer buy | UBS AG | |
| 25.07.12 | Pfizer outperform | Sanford C. Bernstein and Co., Inc. | |
| 20.07.12 | Pfizer buy | UBS AG | |
| 18.07.12 | Pfizer buy | UBS AG | |
| 17.07.12 | Pfizer overweight | JP Morgan Chase & Co. | |
| 16.07.12 | Pfizer buy | Jefferies & Company Inc. | |
| 19.06.12 | Pfizer overweight | JP Morgan Chase & Co. | |
| 10.05.12 | Pfizer buy | UBS AG | |
| 03.05.12 | Pfizer buy | UBS AG | |
| 03.05.12 | Pfizer overweight | JP Morgan Chase & Co. | |
| 02.05.12 | Pfizer outperform | Sanford C. Bernstein and Co., Inc. | |
| 24.04.12 | Pfizer buy | Jefferies & Company Inc. | |
| 28.03.12 | Pfizer buy | Goldman Sachs Group Inc. | |
| 27.03.12 | Pfizer outperform | Sanford C. Bernstein and Co., Inc. | |
| 20.03.12 | Pfizer buy | Jefferies & Company Inc. | |
| 23.02.12 | Pfizer buy | UBS AG | |
| 02.02.12 | Pfizer outperform | Credit Suisse Group | |
| 31.01.12 | Pfizer outperform | Sanford C. Bernstein and Co., Inc. | |
| 24.01.12 | Pfizer overweight | JP Morgan Chase & Co. | |
| 12.01.12 | Pfizer buy | UBS AG | |
| 10.01.12 | Pfizer buy | Goldman Sachs Group Inc. | |
| 09.01.12 | Pfizer outperform | Sanford C. Bernstein and Co., Inc. | |
| 13.12.11 | Pfizer buy | UBS AG | |
Werbung
Werbung
